Pyrexia, commonly known as fever, is a frequently encountered symptom in clinical practice. Despite its ubiquity, the management of pyrexia often poses a challenge due to its multifaceted etiology and variable clinical manifestations. This article aims to provide a comprehensive approach to fever management in clinical practice.
The genesis of fever is complex and involves the interplay of various inflammatory mediators, including cytokines and prostaglandins. These mediators act on the hypothalamus, raising the body's thermostat. It's crucial to understand this mechanism to effectively manage pyrexia and treat its underlying cause.
Thorough history taking and physical examination are paramount in fever management. The history should focus on the duration, pattern of fever, associated symptoms, and possible exposure to infectious agents. Physical examination should aim to identify signs of localized infections or systemic diseases.
Investigations should be guided by the clinical suspicion. Basic investigations include complete blood count, urine analysis, and chest X-ray. In cases where the cause remains elusive, more specialized investigations such as cultures, serology, or imaging studies may be required.
Management of pyrexia involves treating the underlying cause and symptomatic relief. Antipyretics are effective for symptom management, but they do not address the underlying cause. Antibiotics, antivirals, or antifungals may be required based on the etiology. Non-pharmacological measures such as hydration and cooling techniques also play a vital role.
Pyrexia is a common yet complex clinical entity. A systematic approach to history taking, examination, and investigations can help identify the underlying cause. Treatment should be etiology-directed and should also focus on symptomatic relief. Through this comprehensive approach, clinicians can effectively manage pyrexia and improve patient outcomes.
1.
Is Laughter Good for Blood Glucose Control?
2.
NIH research cuts leave cancer patient facing hard choice
3.
Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.
4.
Ruxolitinib Reduces Acute GVHD in Transplant Patients
5.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
1.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
2.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
3.
Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons
4.
Biomarkers of Marrow Regenerative Capacity Following Repeated Hematopoietic Stress
5.
Consensus Recommendations for Healthy Hematologic Aging
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
3.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation